Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention
Authors:
Open Access
- 1 August 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 22 (8) , 1119-1129
Abstract
The incidence rate of esophageal adenocarcinoma (EAC) has increased sharply in the past 30 years. Many risk factors have been identified and gastroesophageal reflux disease (GERD) is the most important one. Columnar-lined esophagus, resulting from GERD, is recognized as a key precursor lesion of EAC. In this article, we review the studies on EAC in humans and animal models. We propose that the pathogenesis of EAC is mainly driven by inflammation and oxidative stress, which are augmented by iron overload. The overproduction of prostaglandin E 2 and leukotriene B 4 and overexpression of their receptors are believed to be major factors in exacerbating inflammation and oxidative stress. Based on this mechanistic understanding, antioxidants, inhibitors of arachidonic acid metabolism enzymes and receptor antagonists of certain eicosanoids are proposed as potential chemopreventive agents for EAC in future studies.Keywords
This publication has 20 references indexed in Scilit:
- Discordant effect of aspirin and indomethacin on intestinal tumor burden inApcMin/+ miceProstaglandins, Leukotrienes and Essential Fatty Acids, 2000
- The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junctionGastroenterology, 1999
- CLINICAL MODELS OF CHEMOPREVENTION FOR THE ESOPHAGUSHematology/Oncology Clinics of North America, 1998
- Interaction of human neutrophils with airway epithelial cells: Reduction of leukotriene B4 generation by epithelial cell derived prostaglandin E2Journal of Cellular Physiology, 1998
- BIOMARKERS FOR MALIGNANCY IN THE COLUMNAR-LINED ESOPHAGUSGastroenterology Clinics of North America, 1997
- Mutations of p53 in barrett's esophagus and barrett's cancer: A prospective study of ninety-eight casesThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Induction of apoptosis by ubenimex (Bestatin®) in human non-small-cell lung cancer cell linesBiomedicine & Pharmacotherapy, 1996
- Aspirin and reduced risk of esophageal carcinomaCancer, 1995
- Altered inflammatory responses in leukotriene-deficient mice.Proceedings of the National Academy of Sciences, 1994
- Review of ubenimex (Bestatin): clinical researchBiomedicine & Pharmacotherapy, 1991